Criticism of REACH registration dossiers is largely unfounded

The chemical-pharmaceutical industry works intensively on implementing the European chemicals regulation REACH. The quality of registration dossiers is a priority for VCI member companies. Currently voiced criticism of dossiers is excessive and largely unfounded. This is emphasised by the German chemical industry association VCI on the occasion of today’s debate in the EU Parliament. VCI director-general Utz Tillmann states: “The chemical industry takes justified criticism of the content and form of REACH dossiers very seriously. For this reason, we once more invite German and European authorities to engage in an intensive dialogue, and we are hoping for a constructive exchange.”

Animal testing is a controversial aspect: According to the REACH Regulation, tests on animals shall be undertaken only as a last resort. This is precisely what the companies are doing, so that they submit alternative information. The issue at stake is mainly about criticism from German public authorities. Since 2014, they have been carrying out a project to evaluate the quality of registration dossiers – where dossiers with alternative information were frequently not deemed “conforming”. From the VCI’s perspective, this distorts the overall picture of the evaluation.

CONTINUE READING ON www.vci.de